4-(4-MORPHOLINYL)-8-PHENYL-3,4,5,6-TETRAHYDRO(1,2)OXATHIINO(5,6-G)(1,3)BENZOTHIAZOLE 2,2-DIOXIDE
UNII FU5X2AJ2BJ
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(4-morpholinyl)-8-phenyl-3,4,5,6-tetrahydro(1,2)oxathiino(5,6-g)(1,3)benzothiazole 2,2-dioxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FU5X2AJ2BJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80379-72-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H20N2O4S2 PUVHZQOWCLHURM-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(4-morpholinyl)-8-phenyl-3,4,5,6-tetrahydro(1,2)oxathiino(5,6-g)(1,3)benzothiazole 2,2-dioxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.